hepat
c
viru
hcv
major
caus
chronic
hepat
liver
diseas
worldwid
tissu
speci
tropism
larg
defin
viral
entri
process
requir
subsequ
product
viral
infect
establish
chronic
infect
review
provid
overview
viral
host
factor
involv
hcv
entri
hepatocyt
summar
understand
molecular
mechan
govern
process
highlight
therapeut
potenti
hosttarget
entri
inhibitor
recent
estim
world
health
organ
indic
approxim
million
individu
infect
hepat
c
viru
hcv
worldwid
vaccin
prevent
hcv
infect
follow
infect
major
individu
develop
chronic
hepat
c
may
subsequ
lead
liver
cirrhosi
cancer
although
chronic
hepat
c
cure
use
directact
antivir
daa
major
individu
chronic
hepat
c
remain
undiagnos
untreat
furthermor
success
antivir
treatment
prevent
reinfect
patient
risk
behavior
recent
launch
global
program
achiev
hcv
elimin
far
minor
countri
implement
measur
aim
elimin
hcv
infect
public
health
threat
within
next
decad
increas
number
diagnosedtr
case
reduc
riski
behavior
defin
popul
contribut
microelimin
hcv
global
erad
hcv
remain
challeng
like
requir
protect
vaccin
hcv
discov
subsequ
classifi
genu
hepaciviru
flavivirida
famili
virus
highli
variabl
rna
viru
classifi
six
major
genotyp
distinct
geograph
distribut
hcv
genom
encod
polyprotein
subsequ
process
three
viral
structur
protein
form
viral
particl
seven
nonstructur
protein
essenti
viral
replic
structur
protein
compris
envelop
glycoprotein
well
capsid
protein
core
core
protein
viral
rna
form
nucleocapsid
surround
lipid
envelop
decor
glycoprotein
drive
viral
entri
chronic
infect
patient
hcv
particl
circul
lipoviro
particl
lvp
ie
virion
associ
lowdens
lowdens
lipoprotein
ldl
vldl
compon
includ
apolipoprotein
b
apob
e
apo
shield
viru
neutral
antibodi
target
hcv
envelop
glycoprotein
associ
hcv
ldlvldl
compon
may
contribut
viral
evas
host
immun
defens
lvp
appear
dynam
structur
composit
influenc
factor
affect
lipid
metabol
electron
microscopi
observ
viral
particl
recent
show
longsuspect
ultrastructur
hcv
line
result
mass
spectrometri
analys
viral
particl
electron
microscopi
confirm
hcv
particl
compris
viral
host
factor
hcv
proteas
also
found
associ
hcv
particl
proteom
studi
viral
entri
first
step
viral
life
cycl
major
target
neutral
antibodi
prevent
product
infect
research
aim
identifi
hcv
receptor
understand
hcv
entri
process
year
increas
knowledg
viral
life
cycl
coupl
technolog
advanc
enabl
develop
ever
sophist
model
system
allow
discoveri
key
host
factor
essenti
hcv
entri
includ
respons
hcv
tissu
speci
tropism
review
deciph
essenti
role
interplay
hcv
entri
led
identif
target
entri
inhibitor
provid
clue
ration
vaccin
design
review
review
provid
overview
viral
host
factor
involv
hcv
entri
hepatocyt
summar
current
understand
molecular
mechan
govern
process
interact
hcv
hepatocyt
lead
viral
entri
larg
depend
interact
host
lipoprotein
compon
viral
envelop
glycoprotein
host
factor
express
hepatocyt
surfac
within
past
two
decad
research
identifi
abund
host
factor
involv
process
lead
viral
attach
hepatocyt
receptormedi
endocytosi
viral
particl
endosom
fusion
use
variou
approach
review
cluster
differenti
scaveng
receptor
class
b
type
srbi
occludin
ocln
four
main
host
factor
mediat
hcv
entri
inde
express
one
sever
host
factor
confer
cell
suscept
infect
hcv
none
factor
individu
confer
tissu
tropism
hcv
ocln
respons
human
speciesspecif
tropism
hcv
addit
four
essenti
entri
factor
addit
host
factor
play
role
hcv
attach
attachmentbind
factor
internalizationfus
cofactor
hcv
infect
hepatocyt
two
distinct
rout
ie
via
cellfre
viru
entri
celltocel
transmiss
summar
host
factor
sequenc
event
lead
initi
viral
attach
releas
hcv
genom
cytosol
hepatocyt
cellfre
viru
entri
pathway
figur
hcv
celltocel
transmiss
describ
section
schemat
represent
cellfre
hepat
c
viru
hcv
entri
pathway
cartoon
summar
host
factor
sequenc
event
lead
initi
viral
attach
lipoviro
particl
lvp
hcv
intern
releas
viral
genom
cytosol
hepatocyt
initi
bind
step
primarili
involv
lipoprotein
compon
lvp
like
rather
unspecif
event
result
concentr
viru
basolater
membran
hepatocyt
exposur
viral
envelop
glycoprotein
domain
enabl
viru
specif
interact
srbi
postbind
format
hcv
coreceptor
complex
essenti
subsequ
viral
intern
via
clathrinmedi
dynamindepend
endocytosi
process
highli
regul
variou
kinas
endocytot
vesicl
ultim
matur
acid
endosom
thu
promot
low
phdepend
hcv
fusion
hcv
infect
occur
via
parenter
rout
hcv
reach
liver
bloodstream
liver
sinusoid
cell
may
captur
circul
lvp
facilit
viral
infect
neighbor
hepatocyt
liver
major
organ
lipid
homeostasi
hepatocyt
express
sever
lipoprotein
receptor
surfac
initi
attach
lvp
hepatocyt
basolater
membran
like
involv
virusassoci
lipoprotein
compon
particularli
apo
viru
envelop
glycoprotein
interact
highli
sulfat
heparan
sulfat
proteoglycan
hspg
particularli
syndecan
ldl
receptor
ldlr
srbi
cell
surfac
figur
interestingli
addit
role
viral
attach
host
factor
shown
also
contribut
later
step
viral
life
cycl
postbind
step
intern
replic
recent
hepat
viru
cellular
receptor
phosphatidylserin
receptor
serv
host
factor
variou
flavivirida
virus
identifi
addit
factor
contribut
hcv
attach
via
interact
phosphatidylserin
expos
hcv
envelop
suggest
interact
may
stabilizeenh
viral
attach
promot
subsequ
interact
main
entri
factor
given
import
virusassoci
lipoproteinderiv
compon
interact
basolater
hepatocyt
membran
variou
lipoprotein
shown
modul
process
eg
high
densiti
lipoprotein
hdl
increas
hcv
figur
schemat
represent
cellfre
hepat
c
viru
hcv
entri
pathway
cartoon
summar
host
factor
sequenc
event
lead
initi
viral
attach
lipoviro
particl
lvp
hcv
intern
releas
viral
genom
cytosol
hepatocyt
initi
bind
step
primarili
involv
lipoprotein
compon
lvp
like
rather
unspecif
event
result
concentr
viru
basolater
membran
hepatocyt
exposur
viral
envelop
glycoprotein
domain
enabl
viru
specif
interact
srbi
postbind
format
hcv
coreceptor
complex
essenti
subsequ
viral
intern
via
clathrinmedi
dynamindepend
endocytosi
process
highli
regul
variou
kinas
endocytot
vesicl
ultim
matur
acid
endosom
thu
promot
low
phdepend
hcv
fusion
hcv
infect
occur
via
parenter
rout
hcv
reach
liver
bloodstream
liver
sinusoid
cell
may
captur
circul
lvp
facilit
viral
infect
neighbor
hepatocyt
liver
major
organ
lipid
homeostasi
hepatocyt
express
sever
lipoprotein
receptor
surfac
initi
attach
lvp
hepatocyt
basolater
membran
like
involv
virusassoci
lipoprotein
compon
particularli
apo
viru
envelop
glycoprotein
interact
highli
sulfat
heparan
sulfat
proteoglycan
hspg
particularli
syndecan
ldl
receptor
ldlr
srbi
cell
surfac
figur
interestingli
addit
role
viral
attach
host
factor
shown
also
contribut
later
step
viral
life
cycl
postbind
step
intern
replic
recent
hepat
viru
cellular
receptor
phosphatidylserin
receptor
serv
host
factor
variou
flavivirida
virus
identifi
addit
factor
contribut
hcv
attach
via
interact
phosphatidylserin
expos
hcv
envelop
suggest
interact
may
stabilizeenh
viral
attach
promot
subsequ
interact
main
entri
factor
given
import
virusassoci
lipoproteinderiv
compon
interact
basolater
hepatocyt
membran
variou
lipoprotein
shown
modul
process
eg
high
densiti
lipoprotein
hdl
increas
hcv
pseudoparticl
hcvpp
entri
cell
culturederiv
hcv
hcvcc
infect
oxid
hdlldl
inhibit
hcvcc
infect
lipoprotein
lipas
report
function
bridg
virusassoci
lipoprotein
hspg
also
modul
hcv
infect
furthermor
recent
studi
report
longchain
fatti
acylcoenzym
inhibit
hcv
attach
target
virusassoci
lipoprotein
initi
attach
step
primarili
involv
lipoprotein
compon
lvp
like
rather
unspecif
event
serv
concentr
virion
basolater
membran
hepatocyt
also
lead
exposur
viral
envelop
glycoprotein
domain
enabl
viru
specif
interact
srbi
figur
three
cell
surfac
factor
act
viral
receptor
contribut
viral
entri
temporallyregul
manner
inde
directli
bind
viral
envelop
glycoprotein
also
interact
therebi
contribut
format
hcv
coreceptor
complex
essenti
subsequ
viral
intern
interestingli
sever
addit
host
factor
associ
entri
factor
shown
also
contribut
hcv
entri
figur
direct
mechan
indirect
regulatori
mechan
see
section
hcv
first
thought
bind
extracellular
loop
srbi
lipid
transfer
activ
srbi
may
facilit
exposur
bind
site
hcv
allow
transfer
viral
particl
key
role
subsequ
entri
step
srbi
also
role
postbind
entri
step
express
level
srbi
shown
defin
viru
intern
rate
demonstr
key
role
srbi
hcv
intern
interestingli
splice
variant
srbi
ie
srbii
also
demonstr
promot
hcvcc
infect
overexpress
affect
intern
rate
suggest
srbi
traffick
play
role
hcv
intern
high
srbi
surfac
express
may
facilit
assembl
protein
complex
srbi
hcv
entri
factor
drive
intern
although
initi
engag
srbi
like
prime
subsequ
interact
recent
shown
small
fraction
virion
abl
achiev
entri
absenc
srbi
critic
postbind
step
hcv
entri
interact
hcv
glycoprotein
bind
activ
signal
pathway
promot
virion
intern
includ
activ
receptor
tyrosin
kinas
epiderm
growth
factor
receptor
egfr
rho
ra
gtpase
activ
egfr
lead
hra
activ
report
promot
actin
rearrang
thu
induc
later
diffus
promot
interact
protein
express
hepatocyt
basolater
membran
tight
junction
format
coreceptor
complex
prerequisit
hcv
entri
role
egfr
regul
associ
essenti
process
howev
egfr
also
propos
help
recruit
clathrinco
vesicl
aid
hcv
intern
consist
egfr
ligand
shown
enhanc
kinet
hcv
entri
induc
endocytosi
complex
kinas
also
suggest
contribut
hcv
entri
downstream
egfr
although
mechan
remain
elucid
activ
egfr
key
role
regul
hcv
entri
process
associ
tight
junction
protein
drive
hcv
intern
compris
four
transmembran
domain
two
extracellular
loop
residu
within
small
highli
conserv
key
viral
entri
genet
evid
suggest
direct
interact
hcv
glycoprotein
furthermor
also
report
complex
interact
wherea
solubl
interestingli
claudin
appear
capabl
mediat
hcv
entri
genotypedepend
manner
function
hcv
entri
factor
genotyp
recent
implic
hcv
entri
well
ocln
anoth
tight
junction
protein
facilit
hcv
uptak
postbind
step
although
mechan
remain
less
clear
like
ocln
four
transmembran
domain
two
larg
extracellular
loop
ocln
shown
essenti
mediat
hcv
entri
possibl
interact
endocytosispromot
gtpase
dynamin
ii
ocln
appear
interact
directli
hcv
particl
ocln
act
similar
step
enabl
hcv
entri
multipl
line
evid
suggest
ocln
critic
late
postbind
entri
step
altern
entri
rout
also
suggest
exampl
report
vldl
receptor
mediat
lipoprotein
uptak
hepatocyt
might
enabl
hcv
enter
hepatocyt
vivo
manner
sinc
hepatoma
cell
line
use
studi
hcv
entri
express
vldlr
classic
cultur
condit
role
host
factor
yet
wide
studi
vitro
hcv
entri
factor
describ
herein
identifi
context
classic
hepatoma
cell
line
recent
develop
sophist
system
allow
valid
factor
condit
close
mimic
vivo
hepat
environ
exampl
singl
particl
imag
polar
hepatoma
organoid
recent
show
hcv
local
srbi
egfr
basolater
membran
actindepend
traffick
tight
junction
part
fit
nice
model
propos
studi
hepatoma
cell
line
sever
factor
shown
contribut
hcv
intern
although
specif
mechan
still
remain
unclear
abl
tyrosin
kinas
recent
identifi
host
factor
hcv
entri
act
clathrinmedi
endocytosi
similarli
transferrin
receptor
play
role
hcv
particl
uptak
although
mechan
signific
still
poorli
understood
niemannpick
cholesterol
absorpt
receptor
also
identifi
hcv
entri
factor
like
contribut
hcv
entri
role
cholesterol
receptor
ultim
interact
entri
factor
promot
hcv
intern
via
clathrinmedi
dynamindepend
endocytosi
figur
although
altern
endocytot
pathway
may
also
play
role
endocytot
vesicl
ultim
matur
acid
endosom
thu
promot
low
phdepend
hcv
fusion
low
endosom
ph
critic
drive
conform
rearrang
glycoprotein
expos
fusion
peptid
howev
interact
viral
glycoprotein
also
thought
prime
viral
particl
fusion
induc
conform
rearrang
hcv
hcv
glycoprotein
form
noncoval
heterodim
mediat
fusion
three
region
glycoprotein
posit
hcv
polyprotein
identifi
play
role
membran
fusion
process
fusion
mechan
hcv
remain
poorli
defin
although
hcv
expect
class
ii
fusion
protein
like
flavivirida
hcv
fusion
machineri
resembl
known
fusion
protein
suggest
hcv
fusion
uniqu
process
compar
fusion
mechan
despit
harbor
central
immunoglobulin
ig
fold
domain
common
among
class
ii
fusion
protein
crystal
structur
reveal
compact
globular
fold
inconsist
highlyextend
class
ii
fusion
fold
given
dispar
known
fusion
protein
propos
although
may
mediat
hcv
entri
interact
cellular
factor
hcv
fusion
protein
inde
form
trimer
featur
typic
fusion
protein
although
trimer
format
depend
coexpress
furthermor
sever
studi
identifi
hydrophob
region
csalyvgdlc
may
repres
put
fusion
peptid
delet
mutant
lack
residu
defect
abil
form
fusion
pore
thu
render
hcv
pseudoparticl
noninfecti
anoth
recent
studi
identifi
central
hydrophob
region
control
requir
low
phdepend
fusion
howev
ntermin
domain
possess
expect
class
ii
fusion
protein
fold
like
small
connect
viral
cellular
membran
therefor
hcv
fusion
like
mediat
depend
intraand
intermolecular
interact
drive
conform
rearrang
heterodim
requir
fusion
consist
model
interact
critic
entri
recent
coevolut
analysi
reveal
refold
interdepend
fusion
chaperonelik
role
like
support
fusion
properti
molecular
detail
underli
precis
heterodim
mediat
membran
fusion
still
remain
elucid
contrast
host
entri
factor
act
receptorscoreceptor
ie
via
direct
interact
hcv
envelop
glycoprotein
other
contribut
regul
viral
entri
without
directli
interact
viral
compon
despit
essenti
viral
entri
process
interact
partner
play
key
role
regul
entri
cellular
factor
regul
local
activ
tight
junction
protein
also
affect
hcv
entri
sever
factor
describ
indirectli
regul
hcv
entri
tetraspanin
form
larg
complex
membran
protein
differ
proteom
approach
identifi
sever
factor
role
hcv
entri
includ
hra
integrin
rasrel
protein
ubiquitin
ligas
casita
blineag
lymphoma
protooncogen
b
cblb
hra
promot
actin
rearrang
may
promot
later
diffus
interact
addit
bind
partner
involv
hcv
entri
includ
serum
respons
factor
bind
protein
recruit
hcv
uptak
thought
act
late
postbind
entri
step
collect
data
suggest
complex
tetraspanin
network
may
provid
platform
hcv
entri
contribut
regul
process
line
studi
shown
contrast
hepatocyt
cell
type
suscept
hcv
express
distinct
partner
restrict
hcv
entri
interestingli
tetraspanin
assembl
emerg
key
platform
regul
entri
unrel
virus
local
cell
surfac
facilit
contact
critic
hcv
entri
sever
factor
affect
local
import
hcv
entri
process
figur
cell
surfac
local
regul
vesicular
transport
protein
associ
enhanc
hcv
entri
tumorassoci
calcium
signal
transduc
interact
ocln
regul
local
protein
kinas
c
pkc
mediat
phosphoryl
recent
studi
show
serotonin
receptor
r
control
local
protein
kinas
pka
mediat
phosphoryl
serotonin
receptor
antagonist
similarli
shown
mediat
local
pkadepend
yet
manner
find
consist
pioneer
studi
demonstr
import
pka
cell
surfac
local
ecadherin
also
import
regul
cellsurfac
local
distribut
ocln
mechan
describ
thought
appli
cellfre
infect
hepatocyt
lvp
distribut
liver
via
bloodstream
follow
initi
hepatocyt
infect
hcv
thought
dissemin
within
liver
use
differ
mechan
includ
cellfre
infect
follow
releas
newli
synthes
viral
particl
infect
hepatocyt
describ
howev
celltocel
transmiss
infect
hepatocyt
adjac
hepatocyt
critic
viral
persist
liver
contrast
cellfre
viru
entri
hcv
celltocel
transmiss
resist
major
neutral
antibodi
howev
process
target
varieti
entri
inhibitor
inde
numer
host
entri
factor
involv
cellfre
hcv
entri
appear
similarli
involv
hcv
celltocel
transmiss
howev
sinc
process
less
extens
studi
cellfre
viru
entri
rel
contribut
viral
host
factor
well
spatiotempor
interplay
remain
less
character
sever
studi
use
variou
approach
shown
srbi
ocln
egfr
ephrin
receptor
ldlr
like
contribut
hcv
celltocel
transmiss
cellfre
entri
srbiindepend
hcv
celltocel
transmiss
report
studi
use
apoesilenc
donor
cell
demonstr
apo
also
play
import
role
process
apo
express
recipi
cell
appear
relev
hcv
celltocel
transmiss
sinc
apo
requir
late
step
morphogenesi
viral
particl
infect
suggest
matur
envelop
viral
particl
transfer
adjac
hepatocyt
line
data
recent
reporterbas
livecel
visual
studi
use
mutant
virus
show
hcv
structur
gene
gene
essenti
function
hcv
celltocel
transmiss
despit
numer
similar
cellfre
entri
celltocel
transmiss
hcv
differ
molecular
mechan
underli
distinct
viral
entri
pathway
report
inde
contrast
cellfre
hcv
entri
appear
requir
unless
hypox
cultur
condit
use
celltocel
transmiss
describ
furthermor
apoevldl
contain
serum
shown
inhibit
cellfre
hcv
infect
interfer
hcv
celltocel
transmiss
indic
although
viral
host
factor
involv
hcv
entri
pathway
overal
subtl
differ
virushost
interact
may
exist
entri
rout
whether
vitro
observ
consequ
dissemin
hcv
vivo
remain
determin
notabl
hcv
rna
contain
exosom
report
howev
whether
extent
exosom
transmit
replic
compet
hcv
genom
protein
andor
virion
remain
matter
debat
approv
daa
therapi
viral
clearanc
rate
use
pegyl
interferon
ribavirin
standardofcar
chronic
hepat
c
therefor
research
activ
investig
altern
antivir
strategi
hcv
includ
develop
entri
inhibitor
essenti
prerequisit
product
viral
infect
hcv
entri
attract
antivir
target
sever
advantag
inhibit
viral
entri
prevent
subsequ
step
viral
life
cycl
limit
viral
dissemin
due
mechan
action
entri
inhibitor
repres
interest
strategi
prevent
graft
infect
hepat
c
patient
undergo
liver
transplant
may
also
valuabl
set
transplant
organ
hcv
posit
donor
entri
inhibitor
also
protect
cell
virusinduc
modif
may
limit
emerg
resist
variant
viral
replic
note
entri
inhibitor
may
synerg
daa
act
complementari
mechan
action
entri
inhibitor
could
therefor
prove
use
combin
therapi
regimen
numer
host
factor
involv
hcv
entri
process
offer
sever
possibl
target
antivir
intervent
inde
sever
entri
factorsinclud
monoclon
antibodi
mab
small
molecul
inhibitorshav
evalu
antivir
target
review
reach
preclin
develop
tabl
clinic
efficaci
remain
demonstr
tabl
host
factor
involv
hcv
entri
suggest
antivir
target
host
factor
hosttarget
entri
inhibitor
eg
monoclon
antibodi
mab
small
molecul
inhibitor
least
reach
vivo
preclin
develop
list
comprehens
list
host
factor
role
hcv
entri
provid
scaveng
receptor
bi
srbi
attach
postbind
celltocel
transmiss
antisrbi
mab
postbind
endocytosi
signal
cellcel
transmiss
mab
postbind
endocytosi
cellcel
transmiss
mab
occludin
ocln
postbind
endocytosi
cellcel
transmiss
antiocln
mab
epiderm
growth
factor
receptor
egfr
postbind
endocytosi
signal
cellcel
transmiss
antiegfr
mab
erlotinib
niemannpick
postbind
fusion
cellcel
transmiss
ezetimid
r
endocytosi
fusion
phenoxybenzamin
given
import
public
health
limit
approach
manag
hcvinfect
patient
prior
field
develop
highli
relev
model
system
tool
studi
viru
result
effort
year
hcv
entri
wellcharacter
process
involv
tremend
array
host
factor
deciph
essenti
role
play
host
factor
viral
entri
led
develop
hosttarget
entri
inhibitor
review
class
antivir
prevent
hcv
infect
may
also
case
clear
establish
hcv
infect
increas
knowledg
viral
host
determin
involv
virushost
interact
lead
viral
entri
also
provid
valuabl
inform
understand
viral
escap
neutral
antibodi
design
protect
vaccin
review
challeng
still
remain
address
global
erad
hcv
furthermor
learn
studi
hcv
entri
may
contribut
understand
entri
pathway
less
wellcharacter
virus
fund
mbz
support
inserm
univers
lyon
impuls
program
idexlyon
state
manag
french
nation
research
agenc
part
invest
futur
program
du
de
la
ligu
contr
le
cancer
ccc
support
research
initi
grant
queen
univers
author
declar
conflict
interest
inserm
univers
strasbourg
aldevrongenovac
file
patent
applic
monoclon
antibodi
target
host
factor
kinas
inhibit
hcv
infect
antivir
target
funder
role
design
studi
collect
analys
interpret
data
write
manuscript
decis
publish
result
